Apricus Biosciences Shares Outstanding 2006-2018 | APRI

Apricus Biosciences shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Apricus Biosciences shares outstanding for the quarter ending June 30, 2018 were 0.023B, a 106.1% increase year-over-year.
  • Apricus Biosciences 2017 shares outstanding were 0.012B, a 82.48% increase from 2016.
  • Apricus Biosciences 2016 shares outstanding were 0.007B, a 31.05% increase from 2015.
  • Apricus Biosciences 2015 shares outstanding were 0.005B, a 25.77% increase from 2014.
Apricus Biosciences Annual Shares Outstanding
(Millions of Shares)
2017 12
2016 7
2015 5
2014 4
2013 3
2012 3
2011 2
2010 1
2009 9
2008 1
2007 1
2006 0
2005 0
Apricus Biosciences Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 23
Q1 2018 16
Q4 2017 12
Q3 2017 13
Q2 2017 11
Q1 2017 8
Q4 2016 7
Q3 2016 7
Q2 2016 6
Q1 2016 6
Q4 2015 5
Q3 2015 5
Q2 2015 5
Q1 2015 5
Q4 2014 4
Q3 2014 4
Q2 2014 4
Q1 2014 4
Q4 2013 4
Q3 2013 4
Q2 2013 3
Q1 2013 3
Q4 2012 3
Q3 2012 3
Q2 2012 3
Q1 2012 2
Q4 2011 2
Q3 2011 2
Q2 2011 2
Q1 2011 2
Q4 2010 2
Q3 2010 1
Q2 2010 1
Q1 2010 1
Q4 2009 9
Q3 2009 1
Q2 2009 1
Q1 2009 1
Q4 2008 1
Q3 2008 1
Q2 2008 1
Q1 2008 1
Q4 2007 0
Q3 2007 1
Q2 2007 1
Q1 2007 0
Q4 2006 0
Q3 2006 0
Q2 2006 0
Q1 2006 0
Q4 2005 0
Q3 2005 0
Q2 2005 0
Q1 2005 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.006B
Apricus Bio operates in the pharmaceutical industry and focuses on research and development in the area of drug delivery. Its proprietary drug delivery technology is called NexACT ?. Backed by revenue generating CRO business, Bio-Quant, Inc. and its NexMed USA subsidiary, Apricus Bio has leveraged the flexibility of its proven NexACT? drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer. Apricus Bio was formerly known as NexMed, Inc and is headquartered in San Diago, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.681B 11.37
Zoetis (ZTS) United States $44.713B 32.45
Grifols (GRFS) Spain $13.377B 16.33
Tilray (TLRY) United States $11.419B 0.00
Neurocrine Biosciences (NBIX) United States $9.877B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.499B 13.98
Nektar Therapeutics (NKTR) United States $6.880B 8.04
Ionis Pharmaceuticals (IONS) United States $6.411B 0.00
Catalent (CTLT) United States $6.001B 25.83
Impax Laboratories (AMRX) United States $5.668B 30.14
Sage Therapeutics (SAGE) United States $5.501B 0.00
United Therapeutics (UTHR) United States $5.326B 6.84
Loxo Oncology (LOXO) United States $4.930B 0.00
FibroGen (FGEN) United States $4.267B 0.00
Endo (ENDP) Ireland $4.044B 5.81
Taro Pharmaceutical Industries (TARO) Israel $3.733B 14.45
Madrigal Pharmaceuticals (MDGL) United States $3.038B 0.00
Aerie Pharmaceuticals (AERI) United States $2.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.585B 0.00
USANA Health Sciences (USNA) United States $2.564B 22.59
Heron Therapeutics (HRTX) United States $2.154B 0.00
TESARO (TSRO) United States $2.027B 0.00
Xencor (XNCR) United States $1.929B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.908B 0.00
PTC Therapeutics (PTCT) United States $1.868B 0.00
Endocyte (ECYT) United States $1.654B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.565B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.508B 18.44
Zogenix (ZGNX) United States $1.496B 0.00
Corcept Therapeutics (CORT) United States $1.401B 21.55
Portola Pharmaceuticals (PTLA) United States $1.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.324B 0.00
Tricida (TCDA) United States $1.268B 0.00
Esperion Therapeutics (ESPR) United States $1.259B 0.00
TherapeuticsMD (TXMD) United States $1.243B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.143B 0.00
ImmunoGen (IMGN) United States $0.930B 0.00
Radius Health (RDUS) United States $0.832B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.781B 0.00
Karyopharm Therapeutics (KPTI) United States $0.726B 0.00
Flexion Therapeutics (FLXN) United States $0.651B 0.00
GlycoMimetics (GLYC) United States $0.574B 0.00
Dova Pharmaceuticals (DOVA) United States $0.569B 0.00
ChemoCentryx (CCXI) United States $0.556B 32.53
Collegium Pharmaceutical (COLL) United States $0.548B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.538B 0.00
Dermira (DERM) United States $0.531B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.484B 0.00
Akebia Therapeutics (AKBA) United States $0.473B 0.00
ArQule (ARQL) United States $0.473B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 32.06
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.462B 0.00
Forty Seven (FTSV) United States $0.462B 0.00
OptiNose (OPTN) United States $0.447B 0.00
Xeris Pharmaceuticals (XERS) United States $0.432B 0.00
Minerva Neurosciences (NERV) United States $0.416B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.411B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.00
Odonate Therapeutics (ODT) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.388B 0.00
Zafgen (ZFGN) United States $0.381B 0.00
Depomed (ASRT) United States $0.365B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.357B 0.00
Aquestive Therapeutics (AQST) United States $0.352B 0.00
Concert Pharmaceuticals (CNCE) United States $0.347B 0.00
KalVista Pharmaceuticals (KALV) United States $0.346B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.340B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.339B 0.00
ElectroCore (ECOR) United States $0.331B 0.00
Mast Therapeutics (SVRA) United States $0.329B 0.00
Aratana Therapeutics (PETX) United States $0.289B 0.00
Majesco Entertainment (PTE) United States $0.268B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.264B 0.00
IMV INC (IMV) Canada $0.264B 0.00
Translate Bio (TBIO) United States $0.259B 0.00
MEI Pharma (MEIP) United States $0.255B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Tyme Technologies (TYME) United States $0.236B 0.00
Ardelyx (ARDX) United States $0.233B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.233B 0.00
Ocular Therapeutix (OCUL) United States $0.232B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.227B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.215B 0.00
Neon Therapeutics (NTGN) United States $0.215B 0.00
Affimed (AFMD) Germany $0.197B 0.00
Galectin Therapeutics (GALT) United States $0.191B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Achaogen (AKAO) United States $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 0.00
Redhill Biopharma (RDHL) Israel $0.175B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Melinta Therapeutics (MLNT) United States $0.173B 0.00
Molecular Templates (MTEM) United States $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.166B 0.00
MediWound (MDWD) Israel $0.162B 0.00
DURECT (DRRX) United States $0.158B 0.00
Recro Pharma (REPH) United States $0.150B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.149B 0.00
ContraFect (CFRX) United States $0.149B 0.00
Lannett Co Inc (LCI) United States $0.144B 1.20
Adherex Technologies (FENC) United States $0.141B 0.00
Infinity Pharmaceuticals (INFI) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.136B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.135B 0.00
ProNAi Therapeutics (SRRA) Canada $0.131B 0.00
Neos Therapeutics (NEOS) United States $0.122B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.121B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
CTI BioPharma (CTIC) United States $0.111B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
Forward Pharma (FWP) Denmark $0.101B 0.00
India Globalization Capital (IGC) United States $0.097B 0.00
BioLineRx (BLRX) Israel $0.096B 0.00
ENTASIS THERAPT (ETTX) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.083B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Immune Design (IMDZ) United States $0.080B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.080B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Natural Alternatives (NAII) United States $0.072B 8.05
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Novan (NOVN) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.055B 0.00
Trillium Therapeutics (TRIL) Canada $0.051B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.050B 40.24
Capnia (SLNO) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.048B 25.05
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
Avenue Therapeutics (ATXI) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 3.84
IsoRay (ISR) United States $0.033B 0.00
Xenetic Biosciences (XBIO) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.032B 0.00
Onconova Therapeutics (ONTX) United States $0.032B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 10.05
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.024B 0.00
Lipocine (LPCN) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.023B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Aradigm (ARDM) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.018B 1.81
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Midatech Pharma (MTP) United Kingdom $0.016B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.014B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00